Prelude Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Prelude Capital Management's RGEN Position: Q4 2024 in Review
Prelude Capital Management sold out of Repligen (RGEN) in Q4 2024, closing a stake of 1,790 shares — an estimated $266K sold.
Prelude Capital Management first reported a position in RGEN in Q3 2013 and held it in 22 quarters. The position peaked at $830K in Q3 2021. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.
- Prelude Capital Management reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
- Prelude Capital Management sold 1,790 Repligen shares in Q4 2024, an estimated $266K.
- Prelude Capital Management first reported a position in Repligen in Q3 2013 and held it in 22 quarters.
- Prelude Capital Management's Repligen position peaked at $830K in Q3 2021.
- 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.
Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.